Windtree Therapeutics appoints Mark Strobeck to Board and names Craig Fraser as Chair

WINDTREE THERAPEUTICS INC /DE/

Appointed Mark Strobeck, Ph.D. to the Board effective June 22, 2023; serves on Audit and Compensation Committees.
Dr. Strobeck is President & CEO of Rockwell Medical; brings biotech/pharma management and M&A experience.
Appointed Craig E. Fraser as Board Chair and Leslie J. Williams as Lead Independent Director, effective June 22, 2023.
Strobeck receives annual cash retainer per non-employee director policy; initial equity grant under evaluation.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mark Strobeck

Director

WINT · WINDTREE THERAPEUTICS INC /DE/

Effective: 2023-06-22
Filed: June 27, 2023, 7:59 PM ET

On June 22, 2023, the board of directors (the “ Board ”) of Windtree Therapeutics, Inc. (the “ Company ”) appointed Mark Strobeck, Ph.D., as a member of the Board, effective as of June 22, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Strobeck was appointed as Director at WINDTREE THERAPEUTICS INC /DE/.

Action: appointed
Role: Director

Exact text from the filing

On June 22, 2023, the board of directors (the “ Board ”) of Windtree Therapeutics, Inc. (the “ Company ”) appointed Mark Strobeck, Ph.D., as a member of the Board, effective as of June 22, 2023

View on SEC.gov

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-23-018566

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.